Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis.

Taejun YoonJung Yoon PyoSung Soo AhnJason Jungsik SongYong-Beom ParkSang-Won Lee

Published in: Arthritis research & therapy (2020)

This was the first study to elucidate the clinical implication of serum IL-16 in patients with AAV. We found that the serum IL-16 level may reflect the cross-sectional VDI scores among AAV-specific indices. Future studies with larger numbers of patients and serial measurements could provide more reliable data on the clinical implications of serum IL-16 in AAV.

Keyphrases

cross sectional
end stage renal disease
gene therapy
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
current status
patient reported
case control